Clinical study of nimotuzumab combined with concurrent radiochemotherapy for treatment of locally advanced cervical cancer

PURPOSE: Nimotuzumab is a humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR) to inhibit tumor growth. Nimotuzumab has demonstrated desirable therapeutic activity in various types of tumors. However, the benefit of nimotuzumab for the treatment of cervical cancer i...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Manag Res
Main Authors: Chen, Wenli, Li, Tao, Wang, Jian, Liang, Long, Huang, Dandan, Yan, Gaoshu, Tian, Ye, Zhang, Xiaoli, Zhang, Wei
Format: Artigo
Jezik:Inglês
Izdano: Dove 2019
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6731987/
https://ncbi.nlm.nih.gov/pubmed/31564975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S191134
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki